ID   GM07439
AC   CVCL_N063
SY   GM17164
DR   CLO; CLO_0013994
DR   CLO; CLO_0016861
DR   Coriell; GM07439
DR   Coriell; GM17164
DR   GEO; GSM569691
DR   GEO; GSM596229
DR   GEO; GSM597063
DR   GEO; GSM617121
DR   GEO; GSM924674
DR   IPD-IMGT/HLA; 23057
DR   Wikidata; Q54842757
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=26621101;
RX   PubMed=29474986;
RX   PubMed=29959025;
RX   PubMed=31401124;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*29:02,68:02; B*42:02,53:01; C*04:CVAF,17:MN; DRB1*04:03,15:03 (IPD-IMGT/HLA=23057).
CC   HLA typing: A*29:02:01,68:02:01; B*42:02:01,53:01:01; C*04:01:01,17:01:01; DPA1*02:02:02,03:01; DPB1*01:01:01,105:01:01; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:02:01; DRB1*04:03:01,15:03:01; DRB4*01:03:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 17
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=16260726; DOI=10.1073/pnas.0508390102;
RA   Harris S.L., Gil G., Robins H., Hu W.-W., Hirshfield K.M., Bond E.,
RA   Bond G., Levine A.J.;
RT   "Detection of functional single-nucleotide polymorphisms that affect
RT   apoptosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:16297-16302(2005).
//
RX   PubMed=20889555; DOI=10.2353/jmoldx.2010.100090;
RA   Pratt V.M., Zehnbauer B.A., Wilson J.A., Epstein-Baak R., Babic N.,
RA   Bettinotti M.P., Buller-Burckle A.M., Butz K.G., Campbell M.,
RA   Civalier C., El-Badry A., Farkas D.H., Lyon E., Mandal S., McKinney J.,
RA   Muralidharan K., Noll L., Sander T., Shabbeer J., Smith C.-Y.H.,
RA   Telatar M., Toji L.H., Vairavan A., Vance C., Weck K.E., Wu A.H.B.,
RA   Yeo K.-T.J., Zeller M., Kalman L.V.;
RT   "Characterization of 107 genomic DNA reference materials for CYP2D6,
RT   CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for
RT   Molecular Pathology collaborative project.";
RL   J. Mol. Diagn. 12:835-846(2010).
//
RX   PubMed=26621101; DOI=10.1016/j.jmoldx.2015.08.005;
RA   Pratt V.M., Everts R.E., Aggarwal P., Beyer B.N., Broeckel U.,
RA   Epstein-Baak R., Hujsak P., Kornreich R., Liao J., Lorier R.,
RA   Scott S.A., Smith C.-Y.H., Toji L.H., Turner A., Kalman L.V.;
RT   "Characterization of 137 genomic DNA reference materials for 28
RT   pharmacogenetic genes: a GeT-RM collaborative project.";
RL   J. Mol. Diagn. 18:109-123(2016).
//
RX   PubMed=29474986; DOI=10.1016/j.jmoldx.2018.01.011;
RA   Pratt V.M., Del Tredici A.L., Hachad H., Ji Y., Kalman L.V.,
RA   Scott S.A., Weck K.E.;
RT   "Recommendations for clinical CYP2C19 genotyping allele selection: a
RT   report of the Association for Molecular Pathology.";
RL   J. Mol. Diagn. 20:269-276(2018).
//
RX   PubMed=29959025; DOI=10.1016/j.jmoldx.2018.05.009;
RA   Bettinotti M.P., Ferriola D., Duke J.L., Mosbruger T.L., Tairis N.,
RA   Jennings L., Kalman L.V., Monos D.S.;
RT   "Characterization of 108 genomic DNA reference materials for 11 human
RT   leukocyte antigen loci: a GeT-RM collaborative project.";
RL   J. Mol. Diagn. 20:703-715(2018).
//
RX   PubMed=31401124; DOI=10.1016/j.jmoldx.2019.06.007;
RA   Gaedigk A., Turner A., Everts R.E., Scott S.A., Aggarwal P.,
RA   Broeckel U., McMillin G.A., Melis R., Boone E.C., Pratt V.M.,
RA   Kalman L.V.;
RT   "Characterization of reference materials for genetic testing of CYP2D6
RT   alleles: a GeT-RM collaborative project.";
RL   J. Mol. Diagn. 21:1034-1052(2019).
//